These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3704939)

  • 1. [Immunologic aspects of acute viral hepatitis at different ages].
    Botsvadze ESh; Katsitadze TK; Kvitashvili AA; Vashakidze ET
    Ter Arkh; 1986; 58(2):55-9. PubMed ID: 3704939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response and the dynamics of the cytolysis syndrome in viral hepatitis A and B].
    Beksler KhM; Osna NA; Novitskii IN; Titovskiĭ VI; Bachinskaia MK
    Ter Arkh; 1986; 58(10):27-8. PubMed ID: 3492059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active rosette-forming lymphocytes in chronic hepatitis.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood T and B cells in patients with acute viral hepatitis A, B and non-A non-B.
    Cargnel A; Rumi MG; Cambieri R; Viganò P; Cancellieri V; Colombo M
    Boll Ist Sieroter Milan; 1982; 61(5):375-82. PubMed ID: 6821443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The outcome of viral hepatitis B and cellular immunity function].
    Matveev VA; Savitskiĭ GI; Ketiladze ES
    Ter Arkh; 1987; 59(7):10-3. PubMed ID: 3499674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of the specific sensitization of immunocytes in assessing the immune response in viral hepatitis B].
    Titov VM
    Vrach Delo; 1991 Feb; (2):54-7. PubMed ID: 1711736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity to the hepatitis B virion in acute hepatitis type B.
    Fattovich G; Alberti A; Crivellaro C; Pontisso P; Noventa F; Realdi G
    Clin Exp Immunol; 1983 Sep; 53(3):645-50. PubMed ID: 6616959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of initial absolute lymphocyte count on persistence of HBs antigenemia in acute viral hepatitis].
    Ptaszkowski K
    Wiad Lek; 1984 Jul; 37(14):1079-81. PubMed ID: 6516361
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.
    Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS
    J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin E in acute viral hepatitis].
    Davydov RR; Fokina AN; Zhukov VP; Davidovich GM
    Klin Med (Mosk); 1993; 71(3):47-9. PubMed ID: 8015218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meaning and development of markers of acute hepatitis].
    Bonazzi L; Raise E; Cuccí AM; Ruffilli E; Lenzi G; Di Salvo S; Pittralis MC
    Minerva Med; 1982 Apr; 73(18):1161-8. PubMed ID: 6281688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis A and hepatitis B. Clinical, epidemiological and differential immunological elements].
    Ortona L; Pizzigallo E; Federico G; Camilli G; Laghi V
    Minerva Med; 1977 Jan; 68(1):13-28. PubMed ID: 834380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behaviour of T and B lymphocytes during the acute phase of viral hepatitis with positive or negative HBsAg.
    Boroń P; Bobrowska E; Boroń-Kaczmarska A; Nadowska K; Szpakowicz T
    Med Interne; 1981; 19(1):79-82. PubMed ID: 6972080
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral rosette forming cells with SRBC-AET in type B acute viral hepatitis.
    Nardiello S; Russo M; Pizzella T; Galanti B
    Boll Ist Sieroter Milan; 1981 Nov; 60(5):426-9. PubMed ID: 6978725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative characteristics of immunologic indices in patients with lung abscesses and viral hepatitis].
    Sokhin AA; Monogarova NE; Kurilova VG; Sliusar' LI; Sokhina GT
    Vrach Delo; 1989 Aug; (8):116-9. PubMed ID: 2588507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.